Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracellular Matrix | 23 | 2025 | 148 | 5.620 |
Why?
|
| Hydrogels | 15 | 2026 | 127 | 4.210 |
Why?
|
| Biocompatible Materials | 14 | 2026 | 154 | 3.590 |
Why?
|
| Polyethylene Glycols | 13 | 2026 | 172 | 2.320 |
Why?
|
| Breast Neoplasms | 7 | 2023 | 1235 | 1.730 |
Why?
|
| Tumor Microenvironment | 7 | 2023 | 183 | 1.510 |
Why?
|
| Astrocytes | 2 | 2024 | 123 | 1.360 |
Why?
|
| Neoplasms | 6 | 2023 | 1377 | 1.330 |
Why?
|
| Brain | 5 | 2024 | 1672 | 1.170 |
Why?
|
| Materials Testing | 3 | 2024 | 89 | 1.160 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2019 | 29 | 1.140 |
Why?
|
| Bone Marrow | 2 | 2021 | 178 | 1.070 |
Why?
|
| Elastic Modulus | 5 | 2020 | 39 | 1.040 |
Why?
|
| Cell Movement | 9 | 2018 | 484 | 1.010 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2018 | 218 | 0.970 |
Why?
|
| Phosphorylcholine | 2 | 2018 | 45 | 0.910 |
Why?
|
| Cell Adhesion | 8 | 2018 | 218 | 0.900 |
Why?
|
| Mechanical Phenomena | 1 | 2024 | 25 | 0.830 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2024 | 97 | 0.820 |
Why?
|
| Needles | 1 | 2024 | 63 | 0.820 |
Why?
|
| Tenascin | 1 | 2023 | 4 | 0.790 |
Why?
|
| Endometrium | 1 | 2023 | 31 | 0.780 |
Why?
|
| Menstrual Cycle | 1 | 2023 | 83 | 0.760 |
Why?
|
| Hippocampus | 1 | 2024 | 277 | 0.740 |
Why?
|
| Cell Line, Tumor | 11 | 2019 | 1573 | 0.720 |
Why?
|
| Sulfhydryl Compounds | 2 | 2023 | 52 | 0.720 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 378 | 0.690 |
Why?
|
| Polymers | 3 | 2024 | 332 | 0.680 |
Why?
|
| Fibronectins | 2 | 2020 | 44 | 0.680 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2013 | 53 | 0.680 |
Why?
|
| Biomechanical Phenomena | 6 | 2024 | 296 | 0.670 |
Why?
|
| Neoplasm Metastasis | 4 | 2021 | 223 | 0.660 |
Why?
|
| Animals | 24 | 2026 | 21492 | 0.650 |
Why?
|
| Antineoplastic Agents | 4 | 2019 | 645 | 0.590 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 3506 | 0.580 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2009 | 66 | 0.570 |
Why?
|
| Humans | 36 | 2026 | 65830 | 0.560 |
Why?
|
| Calpain | 1 | 2018 | 8 | 0.560 |
Why?
|
| Integrin alpha6 | 1 | 2018 | 20 | 0.550 |
Why?
|
| Foreign-Body Reaction | 1 | 2018 | 16 | 0.550 |
Why?
|
| Niacinamide | 2 | 2017 | 33 | 0.550 |
Why?
|
| Phenylurea Compounds | 2 | 2017 | 32 | 0.550 |
Why?
|
| Maleimides | 1 | 2018 | 9 | 0.550 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 286 | 0.550 |
Why?
|
| Lung | 2 | 2023 | 969 | 0.530 |
Why?
|
| ErbB Receptors | 1 | 2018 | 128 | 0.520 |
Why?
|
| Stress, Mechanical | 8 | 2024 | 119 | 0.490 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2025 | 39 | 0.490 |
Why?
|
| Cytoskeleton | 3 | 2019 | 141 | 0.440 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2025 | 89 | 0.440 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 235 | 0.430 |
Why?
|
| rhoA GTP-Binding Protein | 3 | 2009 | 27 | 0.410 |
Why?
|
| Cell Survival | 4 | 2026 | 588 | 0.400 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2014 | 198 | 0.390 |
Why?
|
| Carcinoma | 1 | 2014 | 130 | 0.390 |
Why?
|
| Cells, Cultured | 7 | 2019 | 2194 | 0.370 |
Why?
|
| Laminin | 2 | 2026 | 81 | 0.370 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 3 | 2008 | 36 | 0.340 |
Why?
|
| Collagen | 3 | 2026 | 135 | 0.340 |
Why?
|
| Tissue Engineering | 3 | 2025 | 148 | 0.340 |
Why?
|
| Integrins | 3 | 2023 | 109 | 0.320 |
Why?
|
| Cell Culture Techniques | 3 | 2008 | 195 | 0.320 |
Why?
|
| Mice | 10 | 2024 | 11185 | 0.300 |
Why?
|
| Female | 12 | 2024 | 34420 | 0.300 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 304 | 0.290 |
Why?
|
| Rheology | 3 | 2020 | 86 | 0.290 |
Why?
|
| Fibroblasts | 2 | 2023 | 423 | 0.290 |
Why?
|
| Focal Adhesions | 4 | 2013 | 24 | 0.280 |
Why?
|
| Cell Communication | 2 | 2019 | 135 | 0.270 |
Why?
|
| MCF-7 Cells | 2 | 2020 | 65 | 0.260 |
Why?
|
| Systems Biology | 2 | 2017 | 36 | 0.240 |
Why?
|
| Proteoglycans | 1 | 2026 | 34 | 0.240 |
Why?
|
| Sulfones | 1 | 2026 | 43 | 0.240 |
Why?
|
| Drug Combinations | 1 | 2026 | 167 | 0.230 |
Why?
|
| Fibrinogen | 3 | 2011 | 33 | 0.220 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2025 | 4 | 0.220 |
Why?
|
| Trypsin | 1 | 2025 | 43 | 0.220 |
Why?
|
| Nanotubes | 1 | 2024 | 24 | 0.210 |
Why?
|
| Pyramidal Cells | 1 | 2024 | 27 | 0.210 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2024 | 42 | 0.210 |
Why?
|
| Pressure | 1 | 2024 | 80 | 0.210 |
Why?
|
| Organoids | 2 | 2025 | 44 | 0.210 |
Why?
|
| Psoriasis | 1 | 2024 | 59 | 0.210 |
Why?
|
| Neuroglia | 1 | 2024 | 81 | 0.200 |
Why?
|
| Brain Concussion | 1 | 2024 | 38 | 0.200 |
Why?
|
| Mass Behavior | 1 | 2023 | 4 | 0.200 |
Why?
|
| Models, Biological | 4 | 2018 | 1193 | 0.200 |
Why?
|
| Epithelium | 1 | 2023 | 100 | 0.190 |
Why?
|
| Faculty | 1 | 2023 | 58 | 0.190 |
Why?
|
| Reproduction | 1 | 2023 | 100 | 0.190 |
Why?
|
| Personnel Selection | 1 | 2023 | 56 | 0.190 |
Why?
|
| Disulfides | 1 | 2023 | 67 | 0.190 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2024 | 263 | 0.190 |
Why?
|
| Cell Division | 1 | 2024 | 451 | 0.190 |
Why?
|
| Explosions | 1 | 2022 | 5 | 0.180 |
Why?
|
| Physical Phenomena | 1 | 2022 | 9 | 0.180 |
Why?
|
| Brain Injuries | 1 | 2024 | 141 | 0.180 |
Why?
|
| Cell Lineage | 1 | 2023 | 282 | 0.170 |
Why?
|
| Genes, Neoplasm | 1 | 2021 | 25 | 0.170 |
Why?
|
| Drug Resistance | 1 | 2022 | 158 | 0.170 |
Why?
|
| Inflammasomes | 1 | 2024 | 352 | 0.160 |
Why?
|
| Biophysics | 2 | 2013 | 42 | 0.160 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2021 | 71 | 0.160 |
Why?
|
| Integrin alpha5beta1 | 1 | 2020 | 6 | 0.160 |
Why?
|
| Epidermal Growth Factor | 2 | 2018 | 49 | 0.160 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2020 | 16 | 0.160 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2020 | 29 | 0.160 |
Why?
|
| Cell Proliferation | 4 | 2013 | 1044 | 0.150 |
Why?
|
| Th17 Cells | 1 | 2020 | 65 | 0.150 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 170 | 0.150 |
Why?
|
| White Matter | 1 | 2020 | 138 | 0.150 |
Why?
|
| Peptides | 1 | 2023 | 593 | 0.150 |
Why?
|
| Lung Compliance | 1 | 2018 | 5 | 0.140 |
Why?
|
| Freezing | 1 | 2018 | 22 | 0.140 |
Why?
|
| Sus scrofa | 1 | 2018 | 30 | 0.140 |
Why?
|
| Swine | 2 | 2020 | 398 | 0.140 |
Why?
|
| Respiratory Mechanics | 1 | 2018 | 56 | 0.140 |
Why?
|
| Phosphorylation | 3 | 2017 | 963 | 0.140 |
Why?
|
| NFATC Transcription Factors | 1 | 2018 | 20 | 0.140 |
Why?
|
| Benchmarking | 1 | 2019 | 137 | 0.140 |
Why?
|
| Acetyl Coenzyme A | 1 | 2018 | 24 | 0.140 |
Why?
|
| Diphenylamine | 1 | 2017 | 4 | 0.140 |
Why?
|
| Endothelial Cells | 1 | 2020 | 216 | 0.130 |
Why?
|
| Stromal Cells | 1 | 2018 | 78 | 0.130 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 28 | 0.130 |
Why?
|
| In Vitro Techniques | 1 | 2018 | 491 | 0.130 |
Why?
|
| Hydrogen | 1 | 2017 | 30 | 0.130 |
Why?
|
| Plastics | 1 | 2017 | 22 | 0.130 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 167 | 0.130 |
Why?
|
| Benzamides | 1 | 2017 | 69 | 0.130 |
Why?
|
| rho-Associated Kinases | 2 | 2009 | 18 | 0.130 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 95 | 0.130 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2017 | 83 | 0.130 |
Why?
|
| Male | 5 | 2024 | 31403 | 0.130 |
Why?
|
| Macrophages | 2 | 2024 | 1042 | 0.130 |
Why?
|
| Multiple Sclerosis | 1 | 2020 | 227 | 0.130 |
Why?
|
| Osteogenesis | 2 | 2009 | 154 | 0.130 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 281 | 0.120 |
Why?
|
| Linear Models | 1 | 2017 | 405 | 0.120 |
Why?
|
| Cystatin C | 1 | 2016 | 9 | 0.120 |
Why?
|
| Cathepsin L | 1 | 2016 | 21 | 0.120 |
Why?
|
| Calcium Signaling | 1 | 2018 | 168 | 0.120 |
Why?
|
| Mice, SCID | 1 | 2017 | 518 | 0.120 |
Why?
|
| Software | 1 | 2020 | 401 | 0.120 |
Why?
|
| Cathepsins | 1 | 2016 | 34 | 0.120 |
Why?
|
| Phosphoproteins | 1 | 2017 | 224 | 0.120 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 526 | 0.120 |
Why?
|
| Feedback, Physiological | 1 | 2016 | 59 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2018 | 161 | 0.120 |
Why?
|
| Leucine | 1 | 2016 | 65 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 408 | 0.120 |
Why?
|
| Aorta | 2 | 2008 | 108 | 0.120 |
Why?
|
| Cell Differentiation | 4 | 2020 | 1391 | 0.120 |
Why?
|
| Actins | 2 | 2008 | 265 | 0.110 |
Why?
|
| Protease Inhibitors | 1 | 2016 | 109 | 0.110 |
Why?
|
| Bacterial Adhesion | 1 | 2015 | 65 | 0.110 |
Why?
|
| Pectins | 1 | 2015 | 63 | 0.110 |
Why?
|
| Organ Specificity | 1 | 2015 | 201 | 0.100 |
Why?
|
| Chitosan | 1 | 2015 | 89 | 0.100 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 80 | 0.100 |
Why?
|
| Staphylococcus aureus | 1 | 2015 | 183 | 0.100 |
Why?
|
| Transcriptome | 1 | 2017 | 408 | 0.100 |
Why?
|
| Elasticity | 3 | 2015 | 47 | 0.100 |
Why?
|
| Fibroblast Growth Factors | 1 | 2013 | 77 | 0.100 |
Why?
|
| Polylysine | 1 | 2013 | 49 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2020 | 714 | 0.100 |
Why?
|
| Mutation | 1 | 2021 | 2675 | 0.090 |
Why?
|
| Heparin | 1 | 2013 | 120 | 0.090 |
Why?
|
| Breast | 1 | 2014 | 194 | 0.090 |
Why?
|
| Chemotaxis | 1 | 2011 | 51 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 3 | 2011 | 401 | 0.090 |
Why?
|
| Cell Polarity | 1 | 2011 | 110 | 0.080 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 240 | 0.080 |
Why?
|
| Phenotype | 1 | 2015 | 1236 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 97 | 0.080 |
Why?
|
| Escherichia coli | 1 | 2015 | 718 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 309 | 0.080 |
Why?
|
| 3T3 Cells | 2 | 2007 | 111 | 0.080 |
Why?
|
| Hepatocytes | 1 | 2011 | 226 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2009 | 61 | 0.070 |
Why?
|
| Ascorbic Acid | 1 | 2009 | 53 | 0.070 |
Why?
|
| Acrylic Resins | 2 | 2006 | 21 | 0.070 |
Why?
|
| Vinculin | 1 | 2008 | 3 | 0.070 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2008 | 111 | 0.070 |
Why?
|
| Cross-Linking Reagents | 1 | 2008 | 119 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2006 | 611 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2008 | 391 | 0.060 |
Why?
|
| Polystyrenes | 1 | 2007 | 35 | 0.060 |
Why?
|
| Muscle Contraction | 1 | 2008 | 209 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2007 | 213 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2007 | 289 | 0.060 |
Why?
|
| Oligopeptides | 1 | 2006 | 135 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2007 | 162 | 0.060 |
Why?
|
| Amides | 1 | 2005 | 61 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 233 | 0.050 |
Why?
|
| Actin Cytoskeleton | 1 | 2005 | 78 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 2329 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2006 | 204 | 0.050 |
Why?
|
| Morphogenesis | 1 | 2025 | 120 | 0.050 |
Why?
|
| Pyridines | 1 | 2005 | 120 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2024 | 115 | 0.050 |
Why?
|
| Liposomes | 1 | 2024 | 118 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2007 | 506 | 0.050 |
Why?
|
| Regeneration | 1 | 2025 | 127 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 238 | 0.050 |
Why?
|
| Melanoma | 1 | 2007 | 335 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 372 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 345 | 0.050 |
Why?
|
| Cell Line | 3 | 2015 | 2031 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2007 | 411 | 0.040 |
Why?
|
| Lipids | 1 | 2024 | 331 | 0.040 |
Why?
|
| Ethiopia | 1 | 2021 | 9 | 0.040 |
Why?
|
| Gray Matter | 1 | 2020 | 43 | 0.040 |
Why?
|
| Time Factors | 1 | 2008 | 3777 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2020 | 194 | 0.040 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2020 | 60 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2020 | 267 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 21 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 1635 | 0.040 |
Why?
|
| Integrin-Binding Sialoprotein | 2 | 2009 | 5 | 0.030 |
Why?
|
| Sialoglycoproteins | 2 | 2009 | 20 | 0.030 |
Why?
|
| Osteocalcin | 2 | 2009 | 46 | 0.030 |
Why?
|
| Nanoparticles | 1 | 2024 | 553 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2018 | 104 | 0.030 |
Why?
|
| Alkaline Phosphatase | 2 | 2009 | 46 | 0.030 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2018 | 17 | 0.030 |
Why?
|
| Acetylation | 1 | 2018 | 121 | 0.030 |
Why?
|
| Communication | 1 | 2023 | 608 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2018 | 287 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 755 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2018 | 134 | 0.030 |
Why?
|
| Collagen Type I | 2 | 2007 | 44 | 0.030 |
Why?
|
| Nanomedicine | 1 | 2016 | 24 | 0.030 |
Why?
|
| RNA Interference | 1 | 2020 | 647 | 0.030 |
Why?
|
| Infant | 1 | 2021 | 1718 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 642 | 0.030 |
Why?
|
| Cytokines | 1 | 2020 | 965 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 2089 | 0.030 |
Why?
|
| Methacrylates | 1 | 2015 | 41 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 377 | 0.030 |
Why?
|
| Protein Transport | 1 | 2016 | 405 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2016 | 283 | 0.030 |
Why?
|
| Glucose | 1 | 2018 | 478 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 588 | 0.030 |
Why?
|
| Histones | 1 | 2018 | 497 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2025 | 3170 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2015 | 149 | 0.030 |
Why?
|
| Nanostructures | 1 | 2016 | 187 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2015 | 465 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2013 | 91 | 0.020 |
Why?
|
| Apoptosis | 1 | 2018 | 1100 | 0.020 |
Why?
|
| Child | 1 | 2021 | 4651 | 0.020 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2011 | 15 | 0.020 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2011 | 17 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2011 | 58 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 5681 | 0.020 |
Why?
|
| Urea | 1 | 2011 | 42 | 0.020 |
Why?
|
| Albumins | 1 | 2011 | 46 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 6367 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2013 | 1161 | 0.020 |
Why?
|
| Bone Matrix | 1 | 2009 | 3 | 0.020 |
Why?
|
| Compliance | 1 | 2009 | 6 | 0.020 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2009 | 3 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 2009 | 21 | 0.020 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2009 | 142 | 0.020 |
Why?
|
| Antioxidants | 1 | 2009 | 252 | 0.020 |
Why?
|
| Fibrin | 1 | 2007 | 19 | 0.020 |
Why?
|
| Rats | 1 | 2011 | 2005 | 0.020 |
Why?
|
| Epidermis | 1 | 2007 | 35 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 372 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 15145 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 17575 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 18498 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 715 | 0.010 |
Why?
|